← Evidence map

TrialMenopause (New York, N.Y.)2019

Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules).

Rogerio A Lobo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2019
2020
2021
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 30694918